Breaking News Instant updates and real-time market news.

2022-07-07 07:03:23 XRTX Xortx Therapeutics $1.29 / + (+0.00%) 07:03 07/07/22 07/07 07:03 07/07/22 07:03	Xortx Therapeutics announces pre-Phase 3 meeting request with FDA XORTX Therapeutics announced that a type B pre-Phase 3 meeting request with the FDA was submitted on Wednesday, July 6, 2022. The meeting is expected to be held in approximately 70 days from today. To date, the Company has completed the research and development activities leading to this request and is advancing its XRx-008 program for the treatment of autosomal dominant polycystic kidney disease. R&D activities during the past year leading to this meeting request included manufacturing clinical quality GMP oxypurinol, finalizing formulation of drug product, and characterizing improved oral bio-availability of oxypurinol in animal models. The company said, "We have achieved successful regulatory filings with the FDA and Health Canada and have commenced our OXY-XRX-101 bridging pharmacokinetics study. These important milestones have positioned XORTX for the next important step - a pre-Phase 3 meeting with the FDA."

2022-07-07 07:03:23

XRTX

Xortx Therapeutics

$1.29 / + (+0.00%)

07:03

07/07/22

07/07

07:03

07/07/22

07:03

Xortx Therapeutics announces pre-Phase 3 meeting request with FDA

XORTX Therapeutics announced that a type B pre-Phase 3 meeting request with the FDA was submitted on Wednesday, July 6, 2022. The meeting is expected to be held in approximately 70 days from today. To date, the Company has completed the research and development activities leading to this request and is advancing its XRx-008 program for the treatment of autosomal dominant polycystic kidney disease. R&D activities during the past year leading to this meeting request included manufacturing clinical quality GMP oxypurinol, finalizing formulation of drug product, and characterizing improved oral bio-availability of oxypurinol in animal models. The company said, "We have achieved successful regulatory filings with the FDA and Health Canada and have commenced our OXY-XRX-101 bridging pharmacokinetics study. These important milestones have positioned XORTX for the next important step - a pre-Phase 3 meeting with the FDA."

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	MTY Food to acquire BBQ Holdings for $17.25 per share » 07:47 08/09/22 08/09 07:47 08/09/22 07:47 MTYFF MTY Food Group $45.74 / + (+0.00%) , BBQ BBQ Holdings $11.74 / +0.19 (+1.65%) MTY Food Group (MTYFF)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BBQ BBQ BBQ Holdings $11.74 / +0.19 (+1.65%) 05/10/22 BBQ Holdings sees FY22 net restaurant revenue $280M-$290M, adj. EPS $1.30-$1.60 03/14/22 BBQ Holdings to change name to Famous Hospitality 03/14/22 BBQ Holdings acquires Barrio Queen for $28M MTYFF BBQ MTYFF MTY Food Group $45.74 / + (+0.00%) 07/15/22 RBC Capital MTY Food Group price target lowered to C$66 from C$68 at RBC Capital 07/11/22 Scotiabank MTY Food Group price target raised to C$64 from C$63 at Scotiabank 06/27/22 National Bank MTY Food Group price target lowered to C$63 from C$70 at National Bank 04/11/22 RBC Capital MTY Food Group price target raised to C$68 from C$66 at RBC Capital BBQ BBQ Holdings $11.74 / +0.19 (+1.65%) BBQ BBQ BBQ Holdings $11.74 / +0.19 (+1.65%) 05/10/22 BBQ Holdings reports Q1 adjusted EPS 11c vs. 9c last year 03/14/22 BBQ Holdings issues 12-month run rate guidance 03/14/22 BBQ Holdings sees 2022 EPS $1.15-$1.45, two est. 93c 03/14/22 BBQ Holdings reports Q4 adjusted EPS 27c, two est. 14c
Hot Stocks	AstroNova acquires Astro Machine for $17.1M in cash » 07:46 08/09/22 08/09 07:46 08/09/22 07:46 ALOT AstroNova $11.94 / +0.16 (+1.36%) AstroNova announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Earnings ALOT AstroNova $11.94 / +0.16 (+1.36%) 06/08/22 AstroNova reports Q1 EPS 6c vs 8c last year 04/14/22 AstroNova reports Q4 EPS (10c), vs. 12c in Q4 last year
Hot Stocks	ZeroFox debuts as public company at Black Hat USA 2022 » 07:46 08/09/22 08/09 07:46 08/09/22 07:46 ZFOX ZeroFox $11.46 / -2.42 (-17.44%) ZeroFox announced its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Earnings	Hilton Grand Vacations backs FY22 adjusted EBITDA view $960M-$990M » 07:46 08/09/22 08/09 07:46 08/09/22 07:46 HGV Hilton Grand Vacations $42.95 / +1.11 (+2.65%) The Company is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events HGV Hilton Grand Vacations $42.95 / +1.11 (+2.65%) 05/09/22 Hilton Grand Vacations sees 2022 Deferral Adjusted EBITDA $600M-$990M 05/09/22 Hilton Grand Vacations board approves $500M share repurchase program 05/09/22 Hilton Grand Vacations expects cost synergies of $150M from Diamond transaction HGV Hilton Grand Vacations $42.95 / +1.11 (+2.65%) 06/28/22 Barclays Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names 06/28/22 Barclays Hilton Grand Vacations initiated with an Overweight at Barclays 03/08/22 Truist Hilton Grand Vacations price target raised to $63 from $60 at Truist 12/06/21 Truist Hilton Grand Vacations price target raised to $60 from $54 at Truist HGV Hilton Grand Vacations $42.95 / +1.11 (+2.65%) 07:42 Today Hilton Grand Vacations reports Q2 EPS with-items 60c, consensus 88c 05/09/22 Hilton Grand Vacations reports Q1 EPS 42c, consensus 64c 03/01/22 Hilton Grand Vacations reports Q4 EPS 62c, one estimate 88c 11:00 Today Hilton Grand Vacations - HGV 09/22/22 Hilton Grand Vacations - HGV
Hot Stocks	Guru Organic Energy becomes energy drink partner for CEBL » 07:45 08/09/22 08/09 07:45 08/09/22 07:45 GUROF Guru Organic Energy $6.93 / + (+0.00%) GURU Organic Energy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GUROF Guru Organic Energy $6.93 / + (+0.00%) 07/21/22 Guru Organic Energy announces normal course issuer bid 06/13/22 GURU Organic Energy launches marketing campaign 05/31/22 GURU Organic Energy partners with The Amazing Race Canada 05/04/22 GURU Organic Energy announces summer event sponsorship calendar GUROF Guru Organic Energy $6.93 / + (+0.00%) 06/15/22 Stifel Guru Organic Energy price target lowered to C$11 from C$15 at Stifel 06/15/22 CIBC Guru Organic Energy downgraded yesterday to Neutral at CIBC 06/14/22 CIBC GURU Organic Energy downgraded to Neutral from Outperformer at CIBC 03/16/22 Stifel GURU Organic Energy price target lowered to C$15 from C$20 at Stifel GUROF Guru Organic Energy $6.93 / + (+0.00%) 06/14/22 GURU Organic Energy reports Q2 EPS (C$0.12) vs. (C$0.04) last year 03/15/22 GURU Organic Energy reports Q1 EPS (C$0.10) vs. (C$0.02) last year
Recommendations	Luminar price target raised to $14 from $12 at Cowen » 07:45 08/09/22 08/09 07:45 08/09/22 07:45 LAZR Luminar / + Cowen analyst Joshua… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LAZR Luminar / + 08/08/22 Luminaris on track to meet or beat 2022 business milestones 06/28/22 Group of 34 companies ask California Governor to allow autonomous trucks 05/25/22 Luminar hires CJ Moore from Apple, Taner Ozcelik for technical team 05/25/22 Luminar up 4% to $8.80 after Bloomberg report of Apple hire LAZR Luminar / + 07/18/22 Deutsche Bank Luminar price target lowered to $15 from $23 at Deutsche Bank 05/19/22 Northland Luminar price target lowered to $13 from $23 at Northland 05/06/22 Citi Luminar price target lowered to $24 from $31 at Citi 04/25/22 Citi Nissan collaboration 'clear positive' for Luminar, says Citi LAZR Luminar / + 08/08/22 Luminar reports Q2 adjusted EPS (18c), consensus (16c) 08/08/22 Notable companies reporting after market close 05/05/22 Luminar reports Q1 EPS (25c), consensus (13c) 05/05/22 Notable companies reporting after market close LAZR Luminar / + 05/25/22 Luminar hires Apple's CJ Moore to lead autonomous software team 05/25/22 Apple Car director leaves for job at Luminar, Bloomberg reports LAZR Luminar / + 05/05/22 Fly Intel: After-Hours Movers 04/18/22 What You Missed This Week in EVs and Clean Energy 04/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/04/22 What You Missed This Week in EVs and Clean Energy LAZR Luminar / + 07/21/22 Luminar Technologies call volume above normal and directionally bullish 06/09/22 Largest borrow rate increases among liquid names 05/11/22 Luminar Technologies put volume heavy and directionally bearish 05/09/22 Luminar Technologies put volume heavy and directionally bearish
Recommendations	Home Depot price target lowered to $311 from $335 at JPMorgan » 07:45 08/09/22 08/09 07:45 08/09/22 07:45 HD Home Depot $311.96 / +2.4 (+0.78%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HD Home Depot $311.96 / +2.4 (+0.78%) 07/28/22 Home Depot announces latest carbon emission reductions 06/27/22 Home Depot adopts HPE GreenLake for Aruba Networking, Aruba ESP 06/12/22 Fly Intel: Top five weekend stock stories 06/07/22 Adobe expands partnership with Home Depot HD Home Depot $311.96 / +2.4 (+0.78%) 06/22/22 MKM Partners Home Depot initiated with a Neutral at MKM Partners 05/20/22 Citi Home Depot price target raised to $348 from $327 at Citi 05/18/22 Piper Sandler Piper raises Lowe's target to $246 after 'highly impressive' margin performance 05/18/22 Truist Home Depot price target lowered to $375 from $405 at Truist HD Home Depot $311.96 / +2.4 (+0.78%) 05/17/22 Home Depot ups FY22 EPS view to up mid single digits from up low single digits 05/17/22 Home Depot reports Q1 EPS $4.09, consensus $3.67 05/16/22 Notable companies reporting before tomorrow's open 05/16/22 Notable companies reporting before tomorrow's open HD Home Depot $311.96 / +2.4 (+0.78%) 06/11/22 Costco, Home Depot worth a look, Barron's says 02/26/22 Lowe's stole hedge away from Home Depot, Barron's says HD Home Depot $311.96 / +2.4 (+0.78%) 05/17/22 What You Missed On Wall Street On Tuesday 05/17/22 What You Missed On Wall Street This Morning 05/17/22 Fly Intel: Pre-market Movers 05/16/22 Here's what Wall Street is saying about Home Depot and Lowe's ahead of earnings 08/16/22 Home Depot - HD HD Home Depot $311.96 / +2.4 (+0.78%) 07/26/22 Home Depot put volume heavy and directionally bearish 05/17/22 Unusually active option classes on open May 17th 04/08/22 Home Depot calls see heavy early volume 02/22/22 Unusually active option classes on open February 22nd
Recommendations	Target price target raised to $190 from $180 at JPMorgan » 07:45 08/09/22 08/09 07:45 08/09/22 07:45 TGT Target $167.03 / +0.77 (+0.46%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TGT Target $167.03 / +0.77 (+0.46%) 07/25/22 Target drops 4% aftert Walmart lowers Q2, FY23 outlook 07/21/22 NovaBay's DERMAdoctor products available at Target, Urban Outfitters 07/07/22 Grove Collaborative expands retail footprint 06/13/22 Minim announces second shelf expansion in Target stores TGT Target $167.03 / +0.77 (+0.46%) 08/01/22 Wells Fargo Wells Fargo upgrades Target to Overweight, raises price target to $195 08/01/22 Wells Fargo Target upgraded to Overweight from Equal Weight at Wells Fargo 07/28/22 DA Davidson Best Buy price target lowered to $88 from $110 at DA Davidson 07/26/22 Evercore ISI Walmart price target lowered to $120 from $135 at Evercore ISI TGT Target $167.03 / +0.77 (+0.46%) 06/07/22 Target sees 2022 revenue growth in low to mid-single digit range 05/18/22 Target expects about $1B of incremental freight costs this year 05/18/22 Target backs FY22 revenue view up low- to mid-single digits, consensus $109.95B 05/18/22 Target reports Q1 adjusted EPS $2.19, consensus $3.06 TGT Target $167.03 / +0.77 (+0.46%) 07/02/22 Bed Bath & Beyond remodeling not working, Barron's says 06/28/22 Target to cover workers' travel to other states for abortions, CNBC says 06/21/22 Target CEO says supply chains aren't getting better, Bloomberg reports 06/11/22 Costco, Home Depot worth a look, Barron's says TGT Target $167.03 / +0.77 (+0.46%) 08/01/22 What You Missed On Wall Street On Monday 08/01/22 What You Missed On Wall Street This Morning 08/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/26/22 Fly Intel: Pre-market Movers 08/17/22 Target - TGT TGT Target $167.03 / +0.77 (+0.46%) 08/08/22 Target call volume above normal and directionally bullish 08/01/22 Unusually active option classes on open August 1st 06/07/22 Unusually active option classes on open June 7th 06/01/22 Unusual call flow in option market yesterday
Recommendations	BJ's Wholesale price target raised to $58 from $57 at JPMorgan » 07:44 08/09/22 08/09 07:44 08/09/22 07:44 BJ BJ's Wholesale $71.07 / +0.57 (+0.81%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options BJ BJ's Wholesale $71.07 / +0.57 (+0.81%) 06/10/22 BJ's Wholesale opens four new clubs in IN, OH, NJ, VA 05/18/22 BJ's Wholesale falls -16.0% 04/06/22 MamaMancini's secures new product placements with tier-1 retailers 03/30/22 BJ's Wholesale launches 'Same-Day Select' service BJ BJ's Wholesale $71.07 / +0.57 (+0.81%) 06/02/22 Jefferies Costco price target raised to $580 from $560 at Jefferies 06/02/22 Jefferies BJ's Wholesale price target raised to $72 from $69 at Jefferies 05/20/22 Deutsche Bank BJ's Wholesale price target raised to $74 from $70 at Deutsche Bank 05/20/22 Citi BJ's Wholesale price target raised to $63 from $58 at Citi BJ BJ's Wholesale $71.07 / +0.57 (+0.81%) 05/19/22 BJ's Wholesale sees 2022 EPS flat year-over-year, consensus $3.28 05/19/22 BJ's Wholesale reports Q1 adjusted EPS 87c, consensus 71c 05/18/22 Notable companies reporting before tomorrow's open 05/18/22 Notable companies reporting before tomorrow's open BJ BJ's Wholesale $71.07 / +0.57 (+0.81%) 06/27/22 Fly Insider: American Woodmark, Coursera among week's notable insider trades 05/19/22 What You Missed On Wall Street On Thursday 05/19/22 What You Missed On Wall Street This Morning 05/19/22 Fly Intel: Pre-market Movers 08/18/22 BJ's Wholesale - BJ BJ BJ's Wholesale $71.07 / +0.57 (+0.81%) 05/19/22 Unusually active option classes on open May 19th
Hot Stocks	Martin Marietta to sell California cement plant for $350M in cash » 07:44 08/09/22 08/09 07:44 08/09/22 07:44 MLM Martin Marietta $353.18 / -2.75 (-0.77%) Martin Marietta Materials… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly MLM Martin Marietta $353.18 / -2.75 (-0.77%) 03/24/22 Martin Marietta to sell Colorado and Texas mixed concrete Operations to Smyrna 03/01/22 Martin Marietta to sell certain West Coast assets to CalPortland for $250M MLM Martin Marietta $353.18 / -2.75 (-0.77%) 07/14/22 Wolfe Research Martin Marietta upgraded to Outperform from Peer Perform at Wolfe Research 07/01/22 DA Davidson Martin Marietta price target lowered to $375 from $450 at DA Davidson 06/03/22 JPMorgan Martin Marietta upgraded to Overweight from Neutral at JPMorgan 02/14/22 DA Davidson Martin Marietta price target lowered to $450 from $465 at DA Davidson MLM Martin Marietta $353.18 / -2.75 (-0.77%) 07/28/22 Martin Marietta sees 2022 revenue $5.77B-$5.91B, consensus $5.86B 07/28/22 Martin Marietta reports Q2 adjusted EPS $3.96, consensus $3.81 05/03/22 Martin Marietta sees FY22 revenue $5.640B-$5.820B, consensus $5.72B 05/03/22 Martin Marietta reports Q1 cont ops EPS 39c, consensus 68c MLM Martin Marietta $353.18 / -2.75 (-0.77%) 06/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Hot Stocks	Quadrant 4 System appoints Donna de Winter as CFO » 07:44 08/09/22 08/09 07:44 08/09/22 07:44 QFOR Quadrant 4 System / + Q4 announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<
Recommendations	Lowe's price target lowered to $210 from $230 at JPMorgan » 07:44 08/09/22 08/09 07:44 08/09/22 07:44 LOW Lowe's $201.88 / +2.74 (+1.38%) JPMorgan analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LOW Lowe's $201.88 / +2.74 (+1.38%) 07/10/22 Fly Intel: Top five weekend stock stories 06/21/22 Lowe's to help builders of the metaverse create new possibilities 05/27/22 Lowe's raises quarterly dividend 31% to $1.05 from 80c per share 05/18/22 Lowe's says gross margin pressure will shift into Q2 LOW Lowe's $201.88 / +2.74 (+1.38%) 08/03/22 Wells Fargo Lowe's price target lowered to $220 from $240 at Wells Fargo 06/22/22 MKM Partners Lowe's initiated with a Neutral at MKM Partners 05/19/22 Jefferies Lowe's price target lowered to $238 from $290 at Jefferies 05/19/22 Truist Lowe's price target lowered to $237 from $283 at Truist LOW Lowe's $201.88 / +2.74 (+1.38%) 05/18/22 Lowe's sees 2022 EPS $13.10-$13.60, consensus $13.38 05/18/22 Lowe's reports Q1 EPS $3.51, consensus $3.22 05/17/22 Notable companies reporting before tomorrow's open 05/17/22 Notable companies reporting before tomorrow's open LOW Lowe's $201.88 / +2.74 (+1.38%) 07/09/22 Lowe's can keep winning even as housing cools, Barron's says 02/26/22 Lowe's stole hedge away from Home Depot, Barron's says LOW Lowe's $201.88 / +2.74 (+1.38%) 05/18/22 What You Missed On Wall Street On Wednesday 05/18/22 What You Missed On Wall Street This Morning 05/18/22 Fly Intel: Pre-market Movers 05/16/22 Here's what Wall Street is saying about Home Depot and Lowe's ahead of earnings LOW Lowe's $201.88 / +2.74 (+1.38%) 08/02/22 Lowe's put volume heavy and directionally bearish 07/26/22 Lowe's put volume heavy and directionally bearish 06/30/22 Lowe's put volume heavy and directionally bearish 06/07/22 Lowe's put volume heavy and directionally bearish
Downgrade	Auxly Cannabis downgraded to Market Perform from Outperform at Raymond James » 07:43 08/09/22 08/09 07:43 08/09/22 07:43 CBWTF Auxly Cannabis / + Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CBWTF Auxly Cannabis / + 07/05/22 Auxly Cannabis receives $6M on sale of Auxly Annapolis Facility 03/31/22 Auxly Cannabis announces 2022 priorities CBWTF Auxly Cannabis / + 07/25/22 Cantor Fitzgerald Auxly Cannabis downgraded to Neutral from Overweight at Cantor Fitzgerald 07/25/22 Cantor Fitzgerald Auxly Cannabis downgraded to Neutral from Overweight at Cantor Fitzgerald 05/13/22 Raymond James Auxly Cannabis price target lowered to C$0.40 from C$0.65 at Raymond James 11/17/21 Desjardins Auxly Cannabis price target lowered to C$0.60 from C$0.75 at Desjardins CBWTF Auxly Cannabis / + 03/31/22 Auxly Cannabis reports 2021 EPS (C$0.04) vs. (C$0.14) last year
Hot Stocks	StarTek special committee announces new acquisition proposal from CSP » 07:43 08/09/22 08/09 07:43 08/09/22 07:43 SRT StarTek $3.35 / -0.09 (-2.62%) The special committee of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SRT StarTek $3.35 / -0.09 (-2.62%) 06/21/22 StarTek provides update on nonbinding proposal by CSP 06/08/22 StarTek partners with Genesys for advanced experience orchestration capability 02/16/22 StarTek appoints Nishit Shah as global CFO, Jayanta Lahiri as global CIO SRT StarTek $3.35 / -0.09 (-2.62%) 03/11/22 Barrington StarTek price target lowered to $6 from $8 at Barrington 03/11/22 B. Riley StarTek price target lowered to $5.50 from $9.50 at B. Riley 12/23/21 B. Riley StarTek go-private offer does not capture prospects, says B. Riley 10/19/21 Fly Intel: Top five analyst initiations SRT StarTek $3.35 / -0.09 (-2.62%) 05/09/22 StarTek reports Q1 adjusted EPS 5c vs. 4c last year 03/10/22 StarTek reports Q4 adjusted EPS 32c vs. 22c last year
Recommendations	Energy Vault price target lowered to $11.50 from $18 at Cowen » 07:43 08/09/22 08/09 07:43 08/09/22 07:43 NRGV Energy Vault $4.95 / +0.48 (+10.74%) Cowen analyst Thomas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NRGV Energy Vault $4.95 / +0.48 (+10.74%) 07/15/22 Energy Vault rises 14.8% 07/14/22 Energy Vault falls -11.5% 06/27/22 Energy Vault joins the Russell 2000 Index 05/16/22 Energy Vault names Josh McMorrow as chief legal officer NRGV Energy Vault $4.95 / +0.48 (+10.74%) 06/29/22 Chardan Energy Vault initiated with a Buy at Chardan 03/22/22 Guggenheim Guggenheim starts Energy Vault at Buy, sees plans as 'ambitious but plausible' 03/21/22 Guggenheim Energy Vault initiated with a Buy at Guggenheim 03/14/22 Goldman Sachs Energy Vault initiated with a Sell at Goldman Sachs NRGV Energy Vault $4.95 / +0.48 (+10.74%) 08/08/22 Energy Vault reports Q2 EPS (5c), consensus (2c) NRGV Energy Vault $4.95 / +0.48 (+10.74%) 07/21/22 Culper issues short report on Energy Vault, sees 'gravitational pull to zero' 07/21/22 Culper Research says short Energy Vault, says 'Vaults' are 'doomed' NRGV Energy Vault $4.95 / +0.48 (+10.74%) 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 03/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/13/22 Week in SPAC News: Quantum computing company D-Wave to merge with DPCM Capital NRGV Energy Vault $4.95 / +0.48 (+10.74%) 07/14/22 Energy Vault Holdings put volume heavy and directionally bearish 07/14/22 Largest borrow rate increases among liquid names 07/05/22 Energy Vault Holdings put volume heavy and directionally bearish 07/01/22 Unusually active option classes on open July 1st
Recommendations	Take-Two price target lowered to $180 from $190 at Oppenheimer » 07:42 08/09/22 08/09 07:42 08/09/22 07:42 TTWO Take-Two $125.49 / -1.7 (-1.34%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TTWO Take-Two $125.49 / -1.7 (-1.34%) 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD 07/20/22 Take-Two's Zynga says 'Star Wars: Hunters' release delayed 07/15/22 Bandai Namco's 'Elden Ring' best selling game in U.S. in June, says NPD TTWO Take-Two $125.49 / -1.7 (-1.34%) 07:36 Today Stifel Take-Two price target lowered to $180 from $195 at Stifel 07:22 Today Morgan Stanley Take-Two price target lowered to $190 from $195 at Morgan Stanley 07:00 Today Baird Take-Two price target lowered to $140 from $145 at Baird 05:53 Today Barclays Take-Two price target raised to $175 from $171 at Barclays TTWO Take-Two $125.49 / -1.7 (-1.34%) 08/08/22 Take-Two sees FY23 revenue $5.73B-$5.8B, consensus $6.32B 08/08/22 Take-Two reports Q2 EPS (76c) vs. $1.30 last year 05/16/22 Take-Two sees Q1 GAAP EPS 80c-90c, consensus 90c 05/16/22 Take-Two sees FY23 GAAP EPS $1.90-$2.15, consensus $5.99 TTWO Take-Two $125.49 / -1.7 (-1.34%) 07/21/22 Europe game sales rose 13.5% year-over-year in 1H22, Gamesindustry.biz says 07/11/22 Rockstar shelved plans for 'Red Dead 2' next-gen upgrade, VGC reports 07/05/22 Take-Two's Rockstar halts development of 'Red Dead,' 'GTA4' remakes, Kotaku says 04/14/22 'Elden Ring' top-selling game in Europe in March, Gamesindustry.biz says TTWO Take-Two $125.49 / -1.7 (-1.34%) 08/02/22 What You Missed This Week in Video Games 07/26/22 What You Missed This Week in Video Games 07/19/22 What You Missed This Week in Video Games 07/12/22 What You Missed This Week in Video Games 09/08/22 Consumer/Media/Entertainment Conference 09/16/22 Take-Two Interactive Software Inc. TTWO Take-Two $125.49 / -1.7 (-1.34%) 06/07/22 Early notable gainers among liquid option names on June 7th 05/25/22 Notable open interest changes for May 25th 05/17/22 Early notable gainers among liquid option names on May 17th 04/22/22 TakeTwo Interactive Software call volume above normal and directionally bullish
Hot Stocks	Xilio Therapeutics appoints Uli Bialucha as CSO » 07:42 08/09/22 08/09 07:42 08/09/22 07:42 XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) Xilio announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 07:42 Today Xilio Therapeutics expects cash to fund requirements into 1H24 07:40 Today Xilio Therapeutics announces preliminary Phase 1 dose-escalation data for XTX101 06/16/22 Xilio Therapeutics announces promotion of Martin Huber to president 05/17/22 Xilio Therapeutics appoints Davis as CBO XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 03/14/22 H.C. Wainwright H.C. Wainwright sees little readthrough for Xilio from Nektar failure 01/10/22 H.C. Wainwright Xilio Therapeutics initiated with a Buy at H.C. Wainwright 11/16/21 Morgan Stanley Xilio Therapeutics initiated with an Overweight at Morgan Stanley 11/16/21 Raymond James Xilio Therapeutics initiated with an Outperform at Raymond James XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 07:41 Today Xilio Therapeutics reports Q2 EPS (90c), consensus (78c) 05/12/22 Xilio Therapeutics reports Q1 EPS (78c), consensus (93c) 03/01/22 Xilio Therapeutics reports Q4 EPS (98c), consensus ($1.17) 22 Oct
Earnings	Blade Air Mobility reports Q2 revenue $35.6M, consensus $26.8M » 07:42 08/09/22 08/09 07:42 08/09/22 07:42 BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) Says Flight Margin of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) 06/23/22 Blade Air Mobility to integrate airport service into JetBlue loyalty program 05/19/22 Blade to acquire transport activities of three air mobility operators for $50M 04/20/22 Blade Air Mobility announces creation of Blade Europe 04/11/22 Blade to provide service between LA and Indio for Festival in the Desert BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) 05/12/22 Deutsche Bank Blade Air Mobility price target lowered to $10 from $15 at Deutsche Bank 02/08/22 JPMorgan JPMorgan sees revenue beat for Blade Air Mobility on Thursday 01/31/22 Citi Blade Air Mobility price target lowered to $13 from $16 at Citi 12/21/21 Oppenheimer Blade Air Mobility price target lowered to $13 from $14 at Oppenheimer BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) 05/10/22 Blade Air Mobility reports Q1 EBITDA ($7.7M) vs. ($2.2M) last year 02/10/22 Blade Air Mobility reports Q4 revenue $24.6M, consensus $16.71M BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) 02/10/22 Fly Intel: After-Hours Movers 08/12/22 Annual Industrials, Energy & Airlines Conference 08:00 Today Blade Air Mobility - BLDE
Earnings	Cronos Group reports Q2 EPS (5c), consensus (5c) » 07:42 08/09/22 08/09 07:42 08/09/22 07:42 CRON Cronos Group $3.58 / +0.165 (+4.83%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CRON Cronos Group $3.58 / +0.165 (+4.83%) 06/27/22 Cronos Group announces partnership with Geocann 06/21/22 Cronos Group, Ginkgo Bioworks announce achievement of THCV equity milestone 06/21/22 Ginkgo Bioworks and Cronos Group achieve THCV productivity milestone 03/21/22 Cronos Group founder Mike Gorenstein returns as CEO CRON Cronos Group $3.58 / +0.165 (+4.83%) 07/28/22 Canaccord Cronos Group upgraded to Buy from Hold at Canaccord 05/11/22 CIBC CIBC upgrades Cronos to buy on 'multiple reasons for optimism' 05/11/22 Canaccord Cronos upgraded to Hold on operational improvements at Canaccord 05/11/22 CIBC Cronos Group upgraded to Outperformer from Neutral at CIBC CRON Cronos Group $3.58 / +0.165 (+4.83%) 05/10/22 Cronos Group reports Q1 EPS (9c), consensus (8c) 03/01/22 Cronos Group reports 2021 EPS ($1.07), consensus (47c) 02/18/22 Cronos Group reports Q3 EPS 21c, consensus (10c) CRON Cronos Group $3.58 / +0.165 (+4.83%) 04/11/22 NJ approves sale of retail marijuana from seven dispensaries, Bloomberg says 04/01/22 U.S. House backs federal marijuana legalization bill, Marijuana Moment reports 03/24/22 House to vote on marijuana legalization bill next week, Marijuana Moment says CRON Cronos Group $3.58 / +0.165 (+4.83%) 08/04/22 Here's What You Missed in Cannabis This Week 07/28/22 Rising High: Exclusive talk with vertically-integrated MSO Greenlight 07/22/22 Sell these stocks now, proven algorithm says 07/21/22 Rising High: Exclusive talk with funding solutions provider FundCanna 08:30 Today Cronos Group - CRON CRON Cronos Group $3.58 / +0.165 (+4.83%) 03/25/22 Unusually active option classes on open March 25th
Hot Stocks	Xilio Therapeutics expects cash to fund requirements into 1H24 » 07:42 08/09/22 08/09 07:42 08/09/22 07:42 XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) Xilio continues to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 07:40 Today Xilio Therapeutics announces preliminary Phase 1 dose-escalation data for XTX101 06/16/22 Xilio Therapeutics announces promotion of Martin Huber to president 05/17/22 Xilio Therapeutics appoints Davis as CBO 04/01/22 Xilio Therapeutics Inc trading resumes XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 03/14/22 H.C. Wainwright H.C. Wainwright sees little readthrough for Xilio from Nektar failure 01/10/22 H.C. Wainwright Xilio Therapeutics initiated with a Buy at H.C. Wainwright 11/16/21 Morgan Stanley Xilio Therapeutics initiated with an Overweight at Morgan Stanley 11/16/21 Raymond James Xilio Therapeutics initiated with an Outperform at Raymond James XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 07:41 Today Xilio Therapeutics reports Q2 EPS (90c), consensus (78c) 05/12/22 Xilio Therapeutics reports Q1 EPS (78c), consensus (93c) 03/01/22 Xilio Therapeutics reports Q4 EPS (98c), consensus ($1.17) 22 Oct

Earnings	Hilton Grand Vacations reports Q2 EPS with-items 60c, consensus 88c » 07:42 08/09/22 08/09 07:42 08/09/22 07:42 HGV Hilton Grand Vacations $42.95 / +1.11 (+2.65%) Reports Q2 revenue $948M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events HGV Hilton Grand Vacations $42.95 / +1.11 (+2.65%) 05/09/22 Hilton Grand Vacations sees 2022 Deferral Adjusted EBITDA $600M-$990M 05/09/22 Hilton Grand Vacations board approves $500M share repurchase program 05/09/22 Hilton Grand Vacations expects cost synergies of $150M from Diamond transaction HGV Hilton Grand Vacations $42.95 / +1.11 (+2.65%) 06/28/22 Barclays Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names 06/28/22 Barclays Hilton Grand Vacations initiated with an Overweight at Barclays 03/08/22 Truist Hilton Grand Vacations price target raised to $63 from $60 at Truist 12/06/21 Truist Hilton Grand Vacations price target raised to $60 from $54 at Truist HGV Hilton Grand Vacations $42.95 / +1.11 (+2.65%) 05/09/22 Hilton Grand Vacations reports Q1 EPS 42c, consensus 64c 03/01/22 Hilton Grand Vacations reports Q4 EPS 62c, one estimate 88c 11:00 Today Hilton Grand Vacations - HGV 09/22/22 Hilton Grand Vacations - HGV
Recommendations	Trex Company price target lowered to $85 from $90 at Truist » 07:41 08/09/22 08/09 07:41 08/09/22 07:41 TREX Trex Company $63.74 / -0.91 (-1.41%) Truist analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TREX Trex Company $63.74 / -0.91 (-1.41%) 08/08/22 Trex Company falls 9% to $58.00 after Q2 results, below-consensus guidance 06/06/22 Trex Company provides railing solutions for University of Texas 05/16/22 Trex expands its decking line with introduction of Trex Transcend Lineage 04/28/22 Trex Company debuts Ocula, newest glass windscreen system TREX Trex Company $63.74 / -0.91 (-1.41%) 05:49 Today Barclays Trex Company price target lowered to $53 from $63 at Barclays 07/15/22 JPMorgan Trex Company price target lowered to $54 from $66 at JPMorgan 07/14/22 Barclays Trex Company price target lowered to $63 from $68 at Barclays 06/08/22 JPMorgan Azek valuation remains attractive versus Trex, says JPMorgan TREX Trex Company $63.74 / -0.91 (-1.41%) 08/08/22 Trex Company sees Q3 revenue $180M-$190M, consensus $355.0M 08/08/22 Trex Company reports Q2 EPS 79c, consensus 68c 05/09/22 Trex Company backs FY22 revenue growth view of double-digits, consensus $1.38B 05/09/22 Trex Company sees Q2 revenue $375M-$385M, consensus $376.52M TREX Trex Company $63.74 / -0.91 (-1.41%) 08/08/22 Fly Intel: After-Hours Movers 05/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/25/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today Jefferies Industrial Conerence
Earnings	Xilio Therapeutics reports Q2 EPS (90c), consensus (78c) » 07:41 08/09/22 08/09 07:41 08/09/22 07:41 XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) "We are encouraged… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 07:40 Today Xilio Therapeutics announces preliminary Phase 1 dose-escalation data for XTX101 06/16/22 Xilio Therapeutics announces promotion of Martin Huber to president 05/17/22 Xilio Therapeutics appoints Davis as CBO 04/01/22 Xilio Therapeutics Inc trading resumes XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 03/14/22 H.C. Wainwright H.C. Wainwright sees little readthrough for Xilio from Nektar failure 01/10/22 H.C. Wainwright Xilio Therapeutics initiated with a Buy at H.C. Wainwright 11/16/21 Morgan Stanley Xilio Therapeutics initiated with an Overweight at Morgan Stanley 11/16/21 Raymond James Xilio Therapeutics initiated with an Outperform at Raymond James XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 05/12/22 Xilio Therapeutics reports Q1 EPS (78c), consensus (93c) 03/01/22 Xilio Therapeutics reports Q4 EPS (98c), consensus ($1.17) 22 Oct
Recommendations	AppLovin price target lowered to $65 from $74 at Oppenheimer » 07:40 08/09/22 08/09 07:40 08/09/22 07:40 APP AppLovin $40.17 / +3.725 (+10.22%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options APP AppLovin $40.17 / +3.725 (+10.22%) 05/18/22 AppLovin CLO sells $3.39M in common stock 05/11/22 Applovin trading resumes 05/11/22 Applovin trading halted, news pending 04/21/22 AppLovin announces Christina Seafort joins as Chief People Officer APP AppLovin $40.17 / +3.725 (+10.22%) 08/08/22 Credit Suisse AppLovin price target lowered to $80 from $100 at Credit Suisse 08/03/22 Stifel AppLovin price target lowered to $50 from $80 at Stifel 07/07/22 Citi AppLovin price target lowered to $62 from $68 at Citi 06/30/22 KeyBanc AppLovin initiated with an Overweight at KeyBanc APP AppLovin $40.17 / +3.725 (+10.22%) 05/11/22 AppLovin cuts FY22 revenue view to $3.14B-$3.44B from $3.55B-$3.85B 05/11/22 AppLovin reports Q1 EPS (31c), consensus (8c) 02/16/22 AppLovin sees FY22 revenue $3.55B-$3.85B, consensus $3.82B 02/16/22 AppLovin reports Q4 EPS 8c, consensus 11c 03 Dec APP AppLovin $40.17 / +3.725 (+10.22%) 06/30/22 AppLovin cuts 12% of workforce, AdExchanger reports APP AppLovin $40.17 / +3.725 (+10.22%) 06/30/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/12/22 Fly Intel: Pre-market Movers 05/11/22 Fly Intel: After-Hours Movers 05/10/22 Fly Intel: After-Hours Movers 08/10/22 AppLovin - APP APP AppLovin $40.17 / +3.725 (+10.22%) 08/02/22 Largest borrow rate increases among liquid names 05/24/22 Applovin call volume above normal and directionally bullish 05/11/22 Applovin options imply 16.2% move in share price post-earnings 02/16/22 Applovin options imply 10.9% move in share price post-earnings
Hot Stocks	Xilio Therapeutics announces preliminary Phase 1 dose-escalation data for XTX101 » 07:40 08/09/22 08/09 07:40 08/09/22 07:40 XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) XTX101, an Fc-enhanced,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 06/16/22 Xilio Therapeutics announces promotion of Martin Huber to president 05/17/22 Xilio Therapeutics appoints Davis as CBO 04/01/22 Xilio Therapeutics Inc trading resumes 04/01/22 Xilio Therapeutics Inc trading halted, volatility trading pause XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 03/14/22 H.C. Wainwright H.C. Wainwright sees little readthrough for Xilio from Nektar failure 01/10/22 H.C. Wainwright Xilio Therapeutics initiated with a Buy at H.C. Wainwright 11/16/21 Morgan Stanley Xilio Therapeutics initiated with an Overweight at Morgan Stanley 11/16/21 Raymond James Xilio Therapeutics initiated with an Outperform at Raymond James XLO Xilio Therapeutics $3.23 / -0.07 (-2.12%) 05/12/22 Xilio Therapeutics reports Q1 EPS (78c), consensus (93c) 03/01/22 Xilio Therapeutics reports Q4 EPS (98c), consensus ($1.17) 22 Oct

Events

Earnings calls, analyst events, roadshows and more

MRMD
Today at 08:00

Marimed - MRMD Conference Calls
FWRG
Today at 08:00

First Watch Restaurant - FWRG Conference Calls
NE
Today at 08:00

Noble Corp. - NE Conference Calls
ESAB
Today at 08:00

ESAB - ESAB Conference Calls
BHC
Today at 08:00

Bausch Health - BHC Conference Calls
BLDE
Today at 08:00

Blade Air Mobility - BLDE Conference Calls
LMND
Today at 08:00

Lemonade - LMND Conference Calls
AXSM
Today at 08:00

Axsome Therapeutics - AXSM Conference Calls
KPLT
Today at 08:00

Katapult - KPLT Conference Calls
KLTR
Today at 08:00

Kaltura - KLTR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord $0.59 MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities $1.45-1.55
Tues	CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler $35.00 6M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies $241.19 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital $16.01 8.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Xortx Therapeutics announces pre-Phase 3 meeting request with FDA

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access